Review of health-related quality of life data in multiple myeloma patients treated with novel agents

Leukemia
Pieter SonneveldM T Petrucci

Abstract

In multiple myeloma (MM), health-related quality of life (HRQoL) data is becoming increasingly important, owing to improved survival outcomes and the impact of treatment-related toxicity on HRQoL. Researchers are more frequently including HRQoL assessments in clinical trials, but analysis and reporting of this data has not been consistent. A systematic literature review assessed the effect of novel agents (thalidomide, bortezomib and lenalidomide) on HRQoL in MM patients, and evaluated the subsequent reporting of these HRQoL results. A relatively small body of literature addresses HRQoL data in MM patients treated with novel MM therapeutic agents: 9 manuscripts and 15 conference proceedings. The literature demonstrates the complementary value of HRQoL when assessing clinical response, progression, overall survival and toxicity. However, weaknesses and inconsistencies in analysis and presentation of HRQoL data were observed, often complicating interpretation of the impact of treatment on HRQoL in MM. Further evaluation of HRQoL in MM patients treated with novel agents is required in larger cohorts, and ideally in head-to-head comparative studies. Additionally, the development of standardised MM-specific best practice guidelines ...Continue Reading

References

Feb 7, 1980·The New England Journal of Medicine·E S SirisR E Canfield
Oct 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·D OsobaJ Latreille
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F CellaJ Brannon
Mar 1, 1996·British Journal of Haematology·F WisløffJ Westin
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D OsobaJ Pater
Aug 26, 1998·The American Journal of Cardiology·W R Daley
May 17, 2000·Journal of Clinical Epidemiology·C W Lee, K N Chi
Aug 23, 2001·Leukemia·V LévyUNKNOWN French Cooperative Group on CLL and Macroglobulinemia
May 11, 2002·BMJ : British Medical Journal·Andrew BottomleyPeter M Fayers
Jun 27, 2003·The New England Journal of Medicine·Paul G RichardsonKenneth C Anderson
Dec 17, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E A CalhounD Cella
Sep 28, 2004·International Journal of Technology Assessment in Health Care·Sotiria PapanicolaouElias Mossialos
Jan 19, 2005·European Journal of Haematology·C A Uyl-de GrootP C Huijgens
Jun 17, 2005·The New England Journal of Medicine·Paul G RichardsonUNKNOWN Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators
Nov 5, 2005·Leukemia·M KoenigsmannJ Frommer
Jan 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dominique DuboisChristine de la Loge
Apr 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sigurdur Yngvi KristinssonMagnus Björkholm
Jun 19, 2007·Journal of Clinical Epidemiology·Muriel VialaDominique Dubois
Jun 19, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K CocksUNKNOWN EORTC Quality of Life Group
Aug 10, 2007·British Journal of Haematology·Guy PrattPaul Moss
Nov 2, 2007·Leukemia·K C AndersonUNKNOWN ASH/FDA Panel on Clinical Endpoints in Multiple Myeloma
Nov 23, 2007·The New England Journal of Medicine·Meletios DimopoulosUNKNOWN Multiple Myeloma (010) Study Investigators
Nov 23, 2007·The New England Journal of Medicine·Donna M WeberUNKNOWN Multiple Myeloma (009) Study Investigators
Aug 30, 2008·The New England Journal of Medicine·Jesús F San MiguelUNKNOWN VISTA Trial Investigators
Nov 14, 2008·Leukemia·A Palumbo, S V Rajkumar
Mar 17, 2009·European Journal of Haematology·Anna T JohnsenMogens Groenvold
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cyrille HulinPhilippe Moreau
Oct 24, 2009·Haematologica·Michael R Tallack, Andrew C Perkins

❮ Previous
Next ❯

Citations

Mar 15, 2014·Journal of the National Cancer Institute·Archie Bleyer
Mar 6, 2015·Expert Review of Hematology·Helena Maes, Michel Delforge
Apr 22, 2015·European Journal of Haematology·Hedwig M BlommesteinCarin A Uyl-de Groot
Apr 4, 2016·Current Hematologic Malignancy Reports·Charlotte PawlynSikander Ailawadhi
Jun 5, 2015·Current Hematologic Malignancy Reports·Hemant S Murthy, William A Wood
Jan 8, 2015·Annals of Hematology·José Ramiro Espinoza-ZamoraLuis F Oñate-Ocaña
Mar 18, 2017·European Journal of Haematology·Don RobinsonAnnette Lam
May 4, 2016·The American Journal of Hospice & Palliative Care·Fiona KielyTony O'Brien
Nov 14, 2018·Expert Opinion on Pharmacotherapy·Paul G RichardsonSagar Lonial
Jan 19, 2019·British Journal of Haematology·Lene Kongsgaard NielsenTobias Wirenfeld Klausen
Oct 29, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rosslyn de WetDavid Joske
May 28, 2019·Contemporary Nurse·Hee-Young Kang, Eun-Young Choi
Jun 1, 2017·American Society of Clinical Oncology Educational Book·Ashley RoskoAngela Dispenzieri
Sep 26, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Katja WeiselHartmut Goldschmidt
Jan 24, 2020·British Journal of Nursing : BJN·Clare Horgan CuffeCatherine McCabe
Sep 26, 2017·Clinical Journal of Oncology Nursing·Beth Faiman
Jan 30, 2019·Leukemia·Giovanni Barosi, Robert Peter Gale
Mar 22, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Francesco SparanoFabio Efficace
Sep 22, 2020·Panminerva Medica·Chandramouli NagarajanClaudio Cerchione
Feb 13, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Seok Jin KimJuhee Cho
Dec 2, 2017·Journal of Pain and Symptom Management·Pasquale NiscolaFabio Efficace

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.